[Pamplona, Spain], October 27, 2025 – Palobiofarma S.L., a biopharmaceutical company dedicated to the discovery and development of innovative drugs for orphan diseases, announced today the achievement of several important milestones in the clinical development of PBF-999, a novel PDE10...